Navigation Links
FDA Approves Cymbalta(R) for the Management of Fibromyalgia
Date:6/16/2008

he dose and if they are pregnant or nursing.

Patients taking Cymbalta may experience dizziness or fainting upon standing. The most common side effects of Cymbalta include nausea, dry mouth, sleepiness, and constipation. This is not a complete list of side effects.

If patients have any questions, they should talk to their doctor before taking Cymbalta.

For full Patient Information, visit http://www.cymbalta.com.

For full Prescribing Information, including Boxed Warning and medication guide, visit http://www.cymbalta.com.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com.

P-LLY

This press release contains forward-looking statements about the potential of Cymbalta for the management of fibromyalgia, and reflects Lilly's current beliefs. However, as with any pharmaceutical product, there are substantial risks and uncertainties in the process of development and commercialization. There is no guarantee that the product will continue to be commercially successful. For further discussion of these and other risks and uncertainties, see Lilly's filings with the United States Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.

(i) Leventhal, LJ. "Management of fibromyalgia." Annals of Internal Medicine. 1999; 131: 850-858.

(ii) Arnold, L, et al. "Fa
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. ClearWay Minnesota(SM) Board Approves $1.4 Million in New Grants to Reduce Tobaccos Harm
2. FDA Approves AstraZenecas Seroquel(R) for Maintenance Treatment in Bipolar Disorder
3. FDA Approves NOVO NORDISKs NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors
4. FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis
5. FDA Approves Health Claim for Brown Rice
6. FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
7. FDA approves HeartMate II mechanical heart pump for heart-failure patients
8. FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD
9. FDA Approves New Once-a-Month Dose of Actonel for Postmenopausal Osteoporosis
10. FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults
11. FDA APPROVES ROTARIX(R) [Rotavirus Vaccine, live, oral], THE FIRST VACCINE LICENSED TO COMPLETE THE ROTAVIRUS IMMUNIZATION SERIES BY FOUR MONTHS OF AGE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... July 26, 2014 PersonalInjurySolicitorsIreland, a ... help to people who have suffered from a ... of both their new company, and a website, ... the new website explained, http://www.personalinjurysolicitorsireland.com/personal-injury-claims , the ... focus of the company is always on the ...
(Date:7/25/2014)... 25, 2014 American motor vehicle owners ... collisions can pay higher premiums for vehicle insurance on ... insurer network to provide SR22 insurance for high risk ... The different coverage network of local agencies providing direct ... search platform now publicly available for any car owner ...
(Date:7/25/2014)... 2014 Consuming too much salt? Overloaded ... , Read the labels! , Learn to decipher the ... relates to health during a "Healthy Eating for You: ... Humility House, 755 Ohltown Road, Austintown. , Registered dietician ... discussion and answer questions. , The presentation is ...
(Date:7/25/2014)... Island (PRWEB) July 25, 2014 Reproductive ... to announce that Dr. Kerri Luzzo, Lead Physician at ... Award" for her professional accomplishments in fertility care and ... , At the 10th Annual PBN Awards ceremony held ... Island, 40 of the most highly regarded, emerging leaders ...
(Date:7/25/2014)... US (PRWEB) July 25, 2014 ... provider of technology-enabled services for the financial, legal, ... its virtual data room business, Merrill DataSite, has ... Year” presented by GrowthBusiness at the M&A Awards ... recognize the achievements of entrepreneurs, management teams, advisors ...
Breaking Medicine News(10 mins):Health News:PersonalInjurySolicitorsIreland.com Announces the Launch of their New Company and Website 2Health News:SR22 Insurance for High Risk Motorists Added to Local Quotes System at Insurer Website Online 2Health News:Learn to Decipher Food Labels at Humility House 2Health News:Dr. Kerri Luzzo of the Reproductive Science Center of Providence Receives “40 Under Forty Award" for Outstanding Professional Accomplishments and Community Outreach 2Health News:Merrill DataSite Recognized as “Technology Provider of the Year” by GrowthBusiness at the M&A Awards 2014 Event 2
... interaction with cyclosporine could lead to fatal complications ... People taking the immunosuppressant cyclosporine should avoid consuming ... and possibly lead to deadly consequences, new research ... rats taking cyclosporine -- commonly used to help ...
... 25 NeuroVasx, Inc., a medical device company that ... stroke, announced today that it has received CE Mark ... is a minimally invasive device for the embolization of ... of an artery in the brain. If ruptured, aneurysms ...
... to Assist Processing Plants.SHREVEPORT, La., March 25 Since ... proven to be effective on the poultry processing line ... Salmonella, E. coli , and Listeria . ... help control Campylobacter by pre-screening birds for their current ...
... The 2008 Frost & Sullivan European ... is presented to Ferring Pharmaceuticals. The award ... providing no-needle injection for human growth hormone ... and ZOMAJET VISION X, innovative no-needle delivery ...
... March 25 /PRNewswire-Asia-FirstCall/ -- China Medical,Technologies, Inc. ... a leading China-based,medical device company that develops, ... announced that the Company received,quality testing certificate ... ,SPR System,) from one of the State ...
... March 25 Curemark, LLC, a drug research and ... announced today that the U.S. Food and Drug Administration ... application to initiate its pivotal Phase III clinical trial ... to begin Phase III clinical trials at multiple sites ...
Cached Medicine News:Health News:Licorice May Block Absorption of Organ Transplant Drug 2Health News:NeuroVasx Receives CE Mark for cPAX Aneurysm Treatment System 2Health News:SteriFx Inc. Provides 'Solutions' to Combat Campylobacter 2Health News:Frost & Sullivan Accolade for Ferring Pharmaceuticals 2Health News:Frost & Sullivan Accolade for Ferring Pharmaceuticals 3Health News:China Medical Technologies Announces Receipt of SFDA Quality Testing Certificate for its SPR-based Analysis System 2Health News:Curemark Receives Investigational New Drug Clearance for CM-AT for Autism 2Health News:Curemark Receives Investigational New Drug Clearance for CM-AT for Autism 3
(Date:7/24/2014)... Inc. (NYSE: MTD ) today announced second ... , Sales in local currency increased by ... Reported sales increased 5% which included a 1% benefit ... as reported (EPS) were $2.49, compared with $2.24 in ... an increase of 9% over the prior-year amount of ...
(Date:7/24/2014)... July 24, 2014 Omnicell, Inc. (NASDAQ: ... medication and supply management solutions and analytics software ... July 31, to discuss the Company,s Second Quarter ... Quarter 2014 earnings conference call and webcastWhen: ... Randall Lipps, chairman, president and chief executive officer ...
(Date:7/24/2014)... VANCOUVER, British Columbia and MENLO PARK, ... Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the company") announced today ... the company,s fiscal year from December 31 to June 30. ... before September 30, 2014. Jeffrey Bacha , ... year end is an important step in achieving our goal ...
Breaking Medicine Technology:Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 14Omnicell to Release Second Quarter 2014 Earnings Results on July 31 2DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 2DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 3
... 28, 2011 Volcano Corporation (NASDAQ: VOLC ... therapy tools designed to enhance the treatment of coronary ... Leslie V. Norwalk, Esq., and Eric J. Topol, M.D., ... Ms. Norwalk currently serves as strategic counsel to EpsteinBeckerGreen, ...
... -- China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or ... the People,s Republic of China, today announced that it has ... Awards in the category of "Best Company in an Emerging ... on November 3, 2011 at the Grosvenor House hotel in ...
Cached Medicine Technology:Volcano Corporation Appoints Leslie V. Norwalk and Dr. Eric J. Topol to Board of Directors 2Volcano Corporation Appoints Leslie V. Norwalk and Dr. Eric J. Topol to Board of Directors 3China Biologic Nominated for the 2011 Scrip Award as Best Company in an Emerging Market 2China Biologic Nominated for the 2011 Scrip Award as Best Company in an Emerging Market 3
... 45° Prism are designed for ... recommended for tractional retinal detachments ... retinal detachment. They can be ... other midperipheral laser applications. Direct ...
... The 45° Prism ... fundus pathologies and are ... detachments (PDR, BRVO etc.) ... They can be used ...
... The Chalam 15° Prism are ... and are recommended for tractional ... and Rhegmatogenus retinal detachment. They ... photocoagulation and other midperipheral laser ...
The Mid Field lens can be used for air/gas exchange and has a bi-concave design to provide the widest field available in a direct image surgical lens....
Medicine Products: